MYND Share Price Performance
CA$0.07
-0.03 (-33.33%)
Price CA$0.07
Share Pricen/a
MYND Life Sciences Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
MYND Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
MYND Life Sciences Inc. Key Details
Last Reported Earnings
Jul 31, 2024
Next Reporting Earnings
n/a
- -0.0073
- -33,177,800.00%
- -54,256,500.00%
- -50.1%
About MYND
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
